Manager TitleAgeSince
Chief Executive Officer 86 31/08/2013
Director of Finance/CFO 55 30/09/2012
Director TitleAgeSince
Chairman 54 11/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-38.68% - - 106K
-0.78%-1.42%+2.96%+21.65% 50.47B
-6.00%-0.75%+447.48%+535.14% 44.56B
-0.24%+0.74%+37.18%+16.26% 43.08B
-1.55%-2.07%+19.83%+71.70% 41.7B
-0.31%-0.83%+19.47%+48.24% 33.21B
-1.79%-3.24%+26.32%+125.06% 16.77B
-0.58%-2.12% - - 16.28B
-0.88%-0.66%+11.63%+27.62% 14.58B
-1.66%-1.25%+78.49%+42.97% 13.92B
Average -1.38%-1.06%+80.42%+111.08% 30.51B
Weighted average by Cap. -1.70%-1.06%+96.28%+129.03%

Financials

2020 2021
Net sales 1.5M 1.74M 1.41M 1.29M 2.42M 166M 2.43M 16.72M 6.52M 83.97M 6.53M 6.39M 278M 1.08M 1.25M 1.01M 922K 1.73M 119M 1.74M 11.99M 4.67M 60.21M 4.68M 4.58M 200M
Net income 14.75M 17.07M 13.82M 12.62M 23.75M 1.63B 23.83M 164M 63.97M 824M 64.1M 62.7M 2.73B -10.57M -12.24M -9.91M -9.05M -17.03M -1.17B -17.09M -118M -45.87M -591M -45.96M -44.96M -1.96B
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33